OVERVIEW

Penn Medicine and the Tara Miller Melanoma Center at the Abramson Cancer Center present a case-based discussion led by a multidisciplinary team of melanoma and cutaneous carcinoma experts from medical oncology, surgery, dermatology and radiation oncology.

The course will review three complex cutaneous oncology cases, discuss workflows, decision-making processes and the team’s coordinated approach to patient care. You will gain insight into the nuanced discussions at Penn’s tumor board meetings including potential treatment options for advanced melanoma, squamous cell carcinoma and Merkel cell carcinoma.

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

• Discuss the importance of a coordinated care approach in the management of melanoma and cutaneous carcinomas
• Describe new approaches to the adjuvant treatment of high-risk stage II melanoma
• Assess the role that medical oncologists, surgeons, dermatologists and radiation oncologists play in cutaneous oncology management
• Describe potential treatment options for melanoma, squamous cell carcinoma and Merkel cell carcinoma

TARGET AUDIENCE

Dermatologists, dermatopathologists, plastic surgeons, medical oncologists, surgical oncologists, radiation oncologists

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits
AMA PRA Category 1 CreditsTM (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)

For more information please visit the official event page.